Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pancreatin + Bile Constituents is a combination digestive enzyme formulation developed by 21st Century Pharmaceuticals. It contains pancreatin, a mixture of lipase, amylase, and protease enzymes derived from mammalian pancreatic tissue, and bile constituents, which are bile acids and salts. This combination is indicated for the treatment of digestive disorders and digestive enzyme deficiency. The mechanism of action involves the enzymatic hydrolysis of dietary fats, proteins, and carbohydrates by the pancreatic enzymes, complemented by the emulsification of fats by bile salts, thereby facilitating nutrient absorption in the gastrointestinal tract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pancreatin + bile constituents.